Effect of frailty on prognosis in patients with metastatic prostate cancer(FRA-PmC study)
Not Applicable
- Conditions
- metastatic prostate cancer
- Registration Number
- JPRN-UMIN000039864
- Lead Sponsor
- Hirosaki University School of Medicine
- Brief Summary
The overall survival was significantly shorter in patients with G8 <13 than that of>=13.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 96
Inclusion Criteria
Not provided
Exclusion Criteria
Not eligible for the standard of care
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome was the effect of frailty on progression-free survival in patients mHNPC and mCRPC.
- Secondary Outcome Measures
Name Time Method Secondary outcomes included safety, overall survival.